glp-1 and mcas It's wild—but true: mast cells actually have receptors on them. So yes, using a GLP-1 agonist for mast cell activation syndrome (MCAS) is a thing—and in some cases, it really helps Emerging Role of GLP-1 Receptor
Description
Fatigue during GLP-1 transitions is common and manageable but should not be ignored
2014;9:e98135
While SheMed provides professional weight loss services and strives to ensure the information shared is accurate and up to date, we make no representations or guarantees as to its accuracy, completeness, or timeliness
Study type: randomized controlled trial
A pill might persuade more patients to take weight-loss drugs
